Latest news & press releases
29 Aug 2024
News
Bioworld: Cumulus raising $50M, spinning GPR68 small molecules into GIO
20 Aug 2024
Press release
Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project
10 June 2024
Press release
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
08 Apr 2024
Press release
University of Eastern Finland (UEF) and Cumulus Oncology announce new collaboration
01 Feb 2024
Press release
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation
08 Jan 2024
Press release
Cumulus Oncology raises £9m in seed financing
17 Jul 2023
Press release
Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets
07 Feb 2023
Press release
Nodus Oncology Secures £2.4m ($2.9m) Investment
08 Sept 2022
Press release
Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme
06 Sept 2022
Press release
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
22 Mar 2022
Press release
Edinburgh cancer discovery accelerator Cumulus hires Chief Scientific Officer with 'invaluable' skills
22 Feb 2022
Press release
Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory
19 Sept 2021
Press release
Cumulus Oncology appoints Edinburgh Uni neuroscience graduate as Chief Operating Officer
22 Mar 2021
Press release
LDC and Cumulus Oncology announce collaboration
13 Jul 2020
Press release
Eos Backs Europe's First Oncology Drug Discovery Accelerator Cumulus
Get in touch
We are interested in talking with asset holders from different sectors, including Universities, Drug Discovery groups as well as Biotech and Pharma companies re-prioritising their oncology portfolio.
